Elicio Therapeutics, Inc. (ELTX)

NASDAQ: ELTX · Real-Time Price · USD

4.110

-0.030 (-0.72%)

At close: Jun 23, 2026, 4:00 PM EDT

4.160

+0.050 (1.22%)

Pre-market: Jun 24, 2026, 4:56 AM EDT

Elicio Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14.95	18.56	17.62	12.89	6.16	88.76
Cash & Short-Term Investments	14.95	18.56	17.62	12.89	6.16	88.76
Cash Growth	-18.54%	5.36%	36.64%	109.45%	-93.06%	156.47%
Other Receivables	-	-	-	-	-	0.81
Total Trade Receivables	-	-	-	-	-	0.81
Other Current Assets	1.25	0.75	3.08	3.45	4.56	1.69
Total Current Assets	16.2	19.31	20.69	16.35	10.72	91.25
Net Property, Plant & Equipment	4.79	5.08	6.19	7.28	8.5	4.44
Long-Term Investments	-	-	-	-	-	0.72
Other Long-Term Assets	1.7	1.47	1.3	3.52	3.45	0.11
Total Assets	22.69	25.86	28.18	27.15	22.66	96.51
Accounts Payable	0.27	0.67	1.04	4.37	2.81	4.71
Accrued Expenses	5.92	6.43	8.42	3.76	1.94	3.22
Current Portion of Leases	1.04	1.01	0.9	0.91	0.69	0.89
Unearned Revenue	-	-	1.17	0.69	1.44	2.3
Other Current Liabilities	3.6	2.62	2.83	0.04	-	0.17
Total Current Liabilities	7.23	8.11	11.52	9.76	6.87	11.3
Long-Term Debt	9.48	9.41	20.03	-	-	-
Long-Term Leases	3.82	4.09	5.11	6.01	6.79	3.48
Other Long-Term Liabilities	-	-	-	-	0.09	0.24
Total Long-Term Liabilities	13.3	13.5	25.14	6.01	6.88	3.71
Total Liabilities	24.13	24.23	39.49	15.77	13.75	15.01
Common Stock	0.19	0.18	0.11	0.1	0	0.3
Treasury Stock	-0.15	-0.15	-0.15	-0.15	-	-
Additional Paid-in Capital	244.14	235.41	183	153.83	4.86	296.45
Accumulated Other Comprehensive Income	-0.12	-0.13	-0.18	-0.2	-	-0.1
Retained Earnings	-245.5	-233.67	-194.1	-142.2	-107.01	-215.14
Total Common Shareholders' Equity	-1.44	1.64	-11.31	11.37	-102.15	81.51
Minority Interest	-	-	-	-	111.06	-
Shareholders' Equity	-1.44	1.64	-11.31	11.37	8.92	81.51
Total Liabilities & Equity	22.69	25.86	28.18	27.15	22.66	96.51
Total Debt	14.34	14.51	26.04	6.92	7.48	4.37
Net Cash (Debt)	0.61	4.05	-8.42	5.98	-1.33	84.39
Net Cash Growth	-84.99%	-	-	-	-	-
Net Cash Per Share	0.04	0.27	-0.69	1.18	-0.90	57.16
Book Value	-1.44	1.64	-11.31	11.37	-102.15	81.51
Book Value Per Share	-0.09	0.11	-0.93	2.25	-69.19	55.21
Tangible Book Value	-1.44	1.64	-11.31	11.37	-102.15	81.51
Tangible Book Value Per Share	-0.09	0.11	-0.93	2.25	-69.19	55.21

SEC Filings: 10-K · 10-Q